Polycyclic polyprenylated acylphloroglucinol derivatives from Hypericum pseudohenryi

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Hypericum pseudohenryi is a plant source of bioactive compounds.
• Polycyclic polyprenylated acylphloroglucinol (PPAP) derivatives are known for diverse biological activities.

Purpose of the Study:

• To isolate and characterize novel PPAP derivatives from Hypericum pseudohenryi.
• To evaluate the anti-inflammatory, anti-cancer, and neural-protective activities of these compounds.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation via NMR, ECD, and X-ray crystallography.
• In vitro screening for anti-inflammatory (NO inhibition), anti-cancer, and neural-protective activities.

Main Results:

• Seven new PPAP derivatives, hypseudohenrins A-G, were identified along with six known analogs.
• Hypseudohenrins B and G exhibited significant nitric oxide (NO) production inhibition (52.56% and 54.01% at 10 μM, respectively).
• Uraloidin A showed a high NO inhibition ratio (90.61%), comparable to the positive control dexamethasone (94.88%).
• No significant anti-cancer or neural-protective activities were observed.

Conclusions:

• The study successfully isolated and characterized novel PPAP derivatives from Hypericum pseudohenryi.
• Hypseudohenrins B, G, and uraloidin A display promising anti-inflammatory potential by inhibiting NO production.
• Further research into these compounds could lead to the development of new anti-inflammatory agents.